NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue161,62615,00019,769
Cost of Revenue1,254--
Gross Profit160,37215,00019,769
Operating Expenses
Research Development121,82794,29181,491
Selling General and Administrative169,90668,08132,480
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-131,361-147,372-94,202
Income from Continuing Operations
Total Other Income/Expenses Net8,3426,2825,273
Earnings Before Interest and Taxes-123,019-141,090-88,929
Interest Expense19,52319,52319,523
Income Before Tax-142,542-141,090-88,929
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-142,542-141,090-88,929
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-142,542-141,090-88,929
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-142,542-141,090-88,929